health - "cancer"

An elderly man in Britain believes he has beaten cancer by drinking a daily glass of broccoli juice.

Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced the launch of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in India for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant chemotherapy.

Introgen Therapeutics, Inc. (NASDAQ:INGN), a developer of targeted molecular therapies for cancer, announced that the company will present the results from its recently completed Phase 3 trial of ADVEXIN in recurrent head and neck cancer at the American Association for cancer Research (AACR) Centennial Conference on Translational cancer medicine 2008: cancer Clinical Trials and Personalized medicine. The conference will be held July 20-23, 2008 at the Hyatt Regency Monterey in Monterey, CA.

GPs risk legal action if they fail to follow GMC guidance - as well as NICE guidelines - when they treat skin cancers, warns the Medical and Dental Defence Union of Scotland (MDDUS) today (Wednesday, 16 July 2008). GMC guidance in Good Medical Practice advises doctors to 'recognise and work within the limits of [their] competence'. The GMC also advises: 'You should be familiar with relevant guidelines and developments that affect your work.

As cancer treatment improves and more people with cancer survive, general practitioners must become more involved in all stages of the cancer journey, according to an editorial by experts in general practice in the latest issue of the Medical Journal of Australia.

A sweeping genetic analysis suggests that the activity of certain genes might someday allow doctors to predict which lung cancer patients need more aggressive therapies and which do not.

A method that could be applied widely to explore genetic basis of cancer drug resistance Why do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs seem to be working well to reduce tumors or hold them in check? Although largely a mystery to scientists, the result when this occurs is all too familiar: patients relapse and in many cases die when their cancers become resistant.

The world's top engineers, physicians and scientists are joining forces to conceptualize, develop and bring to reality the future tools and treatments of 21st century health care through UC San Diego's new Institute of Engineering in medicine. Nanoparticle bombs to kill cancer, molecular-sized bridges to repair damaged hearts, and scarless surgery techniques are now on the frontier of medical innovations in California with the new Institute leading the way.

(Cell Transplantation Center of Excellence for Aging and Brain Repair) Acute graft-versus-host disease occurs when an immune response is elicited by the grafted cells against a recipient, resulting in tissue damage for the treated individual. There are no definitive markers for predicting the development or progression of GVHD following the transplant of allogenic stem cells as therapy for liver cancer. This study offers a preliminary 'molecular signature' for the development of acute GVHD based on altered gene expression.

The National Human Genome Research Institute, one of the National Institutes of health, has announced grants expected to total about $31 million over the next four years for research aimed at gaining a better understanding of how specific genetic variants act to influence the risk of diabetes, heart disease, cancer and other common diseases.